Cenegermin-Bkbj

Common brands: Oxervate, Vitamin D, Lipitor, Ecotrin, Aspirin 325

Top reporter: Domp Farmaceutici S.P.A.

Recombinant Human Nerve Growth Factor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]HMG-CoA Reductase Inhibitor [EPC]Provitamin D2 Compound [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]
11,984
Total Reports
265
Serious Reports
206
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.72%)

Patient Demographics

Male
3,465
Female
8,092

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Cenegermin-Bkbj.

# Reaction Reports % of Total
1 EYE PAIN 5,856
25.0%
2 EYE IRRITATION 1,875
8.0%
3 PRODUCT DOSE OMISSION ISSUE 1,346
5.7%
4 OCULAR HYPERAEMIA 1,229
5.2%
5 PHOTOPHOBIA 1,067
4.6%
6 VISION BLURRED 949
4.1%
7 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 902
3.8%
8 EYE SWELLING 849
3.6%
9 OCULAR DISCOMFORT 799
3.4%
10 LACRIMATION INCREASED 738
3.1%
11 EYELID PAIN 707
3.0%
12 HEADACHE 674
2.9%
13 PRODUCT ADMINISTRATION ERROR 616
2.6%
14 DRY EYE 541
2.3%
15 OFF LABEL USE 524
2.2%
16 DRUG INEFFECTIVE 499
2.1%
17 FOREIGN BODY SENSATION IN EYES 488
2.1%
18 THERAPY INTERRUPTED 487
2.1%
19 PERIORBITAL PAIN 477
2.0%
20 INTENTIONAL PRODUCT MISUSE 348
1.5%
21 EYE DISCHARGE 314
1.3%
22 ACCIDENTAL OVERDOSE 294
1.3%
23 VISUAL IMPAIRMENT 279
1.2%
24 DEVICE USE ISSUE 278
1.2%
25 SWELLING OF EYELID 255
1.1%
26 HOSPITALISATION 250
1.1%
27 EYE PRURITUS 209
0.9%
28 PRODUCT STORAGE ERROR 200
0.9%
29 EYE INFLAMMATION 191
0.8%
30 EYE INFECTION 188
0.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.